TABLE 2.
Novel calcium nano-formulations show great tumor-suppressive effects.
| Type | Therapy | Calcium nano-formulation | Cancer type | References |
|---|---|---|---|---|
| CaCO 3 | Calcium overload | CaCO3@KAE | Lung cancer | Li et al. (2021c) |
| Calcium overload, CT | PEG CaNMCUR+CDDP | Breast cancer | Zheng et al. (2021b) | |
| Calcium overload, PT | CaCO3@COF-BODIPY-2I@GAG | Colon cancer, breast cancer | Guan et al. (2020) | |
| Calcium overload, IT | OVA@CaCO3 | Colon cancer | An et al. (2020) | |
| Calcium overload, CT, SDT | ECaC nano-system | Colon cancer | Li et al. (2022) | |
| Calcium overload, CT, CDT | CM@CaCO3@SAF NPs@DOX | Lung cancer | Yao et al. (2022b) | |
| Calcium overload, CDT, SDT | Cu/CaCO3 @Ce6 | Breast cancer | Zhao et al. (2022) | |
| Calcium overload, CDT, PT, IT | Cu2O@CaCO3 | Colon cancer | Chang et al. (2020) | |
| CaP | Calcium overload | LDM | Lung cancer | Fu et al. (2023) |
| Calcium overload, CT | RGD-CaPO/DOX | Ovarian cancer | Qiu et al. (2022) | |
| Calcium overload, PT | GMCD | Breast cancer | Fu et al. (2021a) | |
| Calcium overload, SDT, IT | TiO2@CaP | Breast cancer | Tan et al. (2021) | |
| Calcium overload, CT, CDT | PGC-DOX | Breast cancer | Fu et al. (2021b) | |
| Calcium overload, IT, PT | MICaP | Breast cancer | Zhu et al. (2023) | |
| CaO₂ | Calcium overload | CaO2@HMSNs-PAA | Prostate cancer | Wu et al. (2020) |
| Calcium overload | SH-CaO2 NPs | Cervical, breast, and lung carcinoma | Zhang et al. (2019) | |
| Calcium overload, CT | CaO2@ZIF-8@DOX@HA | Ovarian cancer | Sun et al. (2021) | |
| Calcium overload, PT | BPQD@CaO2 -PEG-GPC3Ab | Liver cancer | Guo et al. (2023) | |
| Calcium overload, CDT | CaO2@TA-FeIII | Breast cancer | Chen et al. (2021) | |
| Calcium overload, IT, PT | CaO2 @CuS-MnO2 @HA | Breast cancer, colon cancer | Huang et al. (2022) | |
| Calcium overload, IT, CDT | (Cu2Se-CaO2) @LA | Breast cancer | Feng et al. (2023) | |
| HAp | Calcium overload | HAPNs | Lung cancer, osteosarcoma, melanoma | Sun et al. (2016), Wu et al. (2019), Wu et al. (2022) |
| Calcium overload, CT | DOX@MSNs/HAP | Liver cancer, breast cancer | Kang et al. (2019) | |
| Calcium overload, PT | GA@HAP/ICG-NPs | Liver cancer | Cheng et al. (2021) | |
| Calcium overload, IT | nHA/GM-CSF hydrogel | Melanoma | Chen et al. (2022) |
CT: chemotherapy; SDT: sonodynamic therapy; PT: phototherapy; CDT: chemodynamic therapy; IT: immunotherapy; CaCO3: calcium carbonate; CaP: calcium phosphate; CaO₂: calcium peroxide; HAp: hydroxyapatite.
The meaning of the bold values are clearer display of different types.